HOME Monday, March 22, 2010
Harness the power of pharmacometrics.
Raise your hand if you wish there was a way to make drug development more efficient. Guess what? There is. It’s called model-based drug development, and it involves using quantitative analysis to better design protocols, determine dosage levels, and figure out other neat stuff that lead to successful regulatory filings. Once you see how incredible (and cost-effective) pharmacometrics can be, you’ll be hooked.
And not to brag, but here at Cognigen, we’re the experts in model-based drug development. In fact, we’ve successfully implemented modeling and simulation strategies for development programs in nearly every therapeutic category, for pharmas both large and small, from preclinical to phase 4. And when a regulatory agency sees you’ve worked with Cognigen, they know your submission is the real deal.
But honestly, this is just the beginning. We continue to push the envelope to make even greater strides in our science. It’s a little thing we like to call "Pharma of the Futuresm". You should check it out.
Knocked My Socks Off!
FROM SECTION: BLOG
Every once in awhile an idea is so cool it knocks your socks off. We want to share those ideas. And we want you to send us ideas that knocked your socks off.
Latest Topic: Lean Production
“Lean” thinking changes the focus to optimizing the flow of products and services through entire value streams that flow horizontally across technologies, assets, and departments to customers.
Pharma Of The Future™
FROM SECTION: BLOG
The pharma industry is evolving at a breakneck pace. But luckily, we're here to keep you up to speed on what's happening in drug development.
Latest Topic: Intro to Pharma of the Future™
The pharma industry has a critical need to establish model-based drug development. The Pharma of the Future™ (PoF) program is a research initiative to support this important enterprise transformation.
Say “heck no” to the status quo with Cognigen University.
FROM SECTION: WORKSHOPS
Is your department or company suffering from a severe case of Development Roadblock Disorder (commonly known as DRD)? Well, Cognigen has just the cure – our training workshops. Maybe it’s time you whet your technical modeling appetite by attending Jill Fiedler-Kelly’s highly acclaimed introduction to population pharmacokinetics. Or perhaps you’re ready to tackle our model-based drug development course – which addresses analysis planning, PK/PD modeling, and clinical trial simulation. And no matter if you’re a scientist or manager, you can benefit from acing one of Ted Grasela’s workshops in enterprise engineering, team communication, or strategic planning for the Pharma of the Future. What’s more, each class is customized, and topics can be combined to meet your organization’s specific needs.
Of course, there’s always room for some extra credit. Look no further than our specialty consulting services – mentorships for scientists, external design reviews at key milestones, and independent forensic reviews of deliverables, presentations, and documentation. These handy services will enhance your ability to monitor project progress, anticipate challenges, and ensure the highest quality deliverables.
So sharpen your #2s, ladies and gentlemen. Cognigen University is in session, and ready to help you kick that nasty DRD for good.
READ MORE